Evaluation & Follow-up of People With Tick-borne Diseases

Status Withdrawn

Clinical Trial Summary

Background: Lyme disease is the most common tick-borne disease in the United States, but other diseases transmitted by ticks have also been on the rise in recent years. Early symptoms of a tickborne disease include fever, headache, fatigue and possible rash. Researchers want to collect information and samples from people with Lyme disease and other tick-borne illnesses to better understand and diagnose these diseases. Objective: To evaluate and follow people with tick-borne diseases to help researchers learn more about these infections. Eligibility: People ages 18 and older who have or are suspected of having a tick-borne infection. Design: Participants will have an initial visit, and visits about 1, 6, and 12 months later. The visits can include a physical exam, blood tests, collection of blood, urine and saliva samples for research, and filling out health-related questionnaires. Participants who have the rash of Lyme disease may be invited to have up to 3 skin punch biopsies of the rash for research.

Clinical Trial Description

Lyme disease is a multisystem illness caused by the spirochete Borrelia burgdorferi and it is the most common vector-borne illness in the United States. Tick-borne disease cases reported to the Center for Disease Control and Prevention (CDC) have been on the rise with over 59,000 cases reported in 2017. This protocol is designed to collaborate with University of Maryland School of Medicine for the purpose of recruiting and enrolling patients with Lyme disease and other tickborne illnesses. This is a natural history study which has the objective of developing a rigorously defined population of patients with Lyme disease and other tick-borne illnesses, per CDC case definitions, to serve as the basis for research in multiple aspects of the infections. These research sub-projects have emphasis in exploring the biological markers of tick-borne infections, developing new diagnostic tests for these infections, assessing the clinical course and outcome of patients with these tick-borne infections, and defining the immunological response to the pathogens. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04318925
Study type	Observational
Source	National Institutes of Health Clinical Center (CC)
Contact
Status	Withdrawn
Phase
Start date	November 13, 2023
Completion date	November 13, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01207739` - Persistent Lyme Empiric Antibiotic Study Europe	Phase 4
Terminated	`NCT04577053` - PEMF Therapy to Treat Lingering Symptoms of Lyme Disease After Treatment With Antibiotics	N/A
Completed	`NCT04867473` - Feasibility of Teleyoga for Treatment of Lyme Disease	N/A
Recruiting	`NCT04038346` - Symptomatic Management of Lyme Arthritis	Phase 3
Completed	`NCT01143558` - Searching for Persistence of Infection in Lyme Disease	Early Phase 1
Terminated	`NCT03581279` - Detection of Borrelia Bacteria in Early Stage Lyme Borreliosis Using the T2Lyme Panel	N/A
Enrolling by invitation	`NCT05041595` - Lyme Disease Diagnostic Assay - Collection of Whole Blood
Recruiting	`NCT03981874` - Peripheral Facial Paralysis Sequelae in Lyme Disease Among Children	N/A
Recruiting	`NCT03963635` - Novel Diagnostics for Early Lyme Disease
Terminated	`NCT03084614` - CD8 Reactivity to Microorganisms in Blood and Breast Milk
Recruiting	`NCT04835792` - Biomarker Study of Previously Treated Lyme Disease Volunteers in Comparison to Healthy Volunteers
Recruiting	`NCT04148222` - A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Lyme Disease
Terminated	`NCT03201042` - Lyme Test Indication Combinations (LyTIC) Study
Completed	`NCT01368341` - Comparing 3 Antibiotic Regimes for Erythema Migrans in General Practice	Phase 4
Terminated	`NCT00958139` - Passive Prophylaxis of Lyme Disease Using Permethrin Treated Clothes	Phase 3
Recruiting	`NCT00001539` - A Comprehensive Clinical, Microbiological and Immunological Assessment of Patients With Suspected Post Treatment Lyme Disease Syndrome and Selected Control Populations
Recruiting	`NCT03501407` - Understanding Tick-borne Diseases
Completed	`NCT04422314` - ImmuneSense Lyme Study
Recruiting	`NCT04719962` - Direct Diagnosis of Disseminated Lyme Borreliosis.	N/A
Recruiting	`NCT05312619` - The Burden of Lyme Disease (BOLD) in a Pandemic - Insights From an Online Cross-sectional and Prospective Cohort Survey

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Evaluation and Follow-up of People With Tick-borne Diseases

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms